血管移植市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

2024 年全球血管移植市場價值為 36 億美元，預計到 2034 年將以 6.9% 的複合年成長率成長至 73 億美元。

心血管疾病盛行率的上升、技術創新、末期腎病（ESRD）發生率的增加以及全球外科手術量的增加，共同推動了血管移植市場的擴張。血管移植是一種用於替代、修復或繞過受損或病變血管的醫療器械，旨在恢復正常的血流。這些移植材料是由合成材料、生物組織或二者的混合物製成。它們廣泛用於治療心血管疾病、動脈瘤和血液透析通路。近年來，生物工程移植、肝素塗層ePTFE移植和混合材料等技術的進步，提高了移植材料的生物相容性，降低了血栓形成風險，並改善了長期通暢率。此外，微創和血管內手術的日益普及、組織工程和可生物分解移植材料的使用增加、藥物洗脫和塗層移植材料的推廣應用以及新興市場的擴張，也共同推動了血管移植行業的成長。

2024年，聚酯移植物市佔率達62.3%。聚酯移植物因其耐用性、優異的生物相容性以及在血管修復和搭橋手術中經證實的長期通暢率而備受青睞。其豐富的臨床應用歷史和在主動脈及周邊血管搭橋手術中的穩定表現贏得了外科醫生的高度信賴，使其成為血管手術中的常用材料。

預計2034年，血液透析通路市場將以6.3%的複合年成長率成長。末期腎病（ESRD）病例的增加以及需要長期血液透析的患者數量的成長，推動了對血管移植的需求。移植血管設計的創新，例如提高通暢率和降低感染風險，進一步促進了該領域的成長。

2024年，北美血管移植市佔率達32.2%。冠狀動脈疾病、周邊動脈疾病和主動脈瘤的高發生率是該地區強勁需求的主要原因。擁有完善的醫院體系，配備專業的血管外科中心，並擁有先進的外科技術，這為開放式手術和腔內血管移植手術的開展提供了支持。

全球血管移植物市場的主要參與者包括庫克醫療（Cook Medical）、戈爾（Gore）、泰爾茂（Terumo）、美敦力（Medtronic）、貝朗（B. Braun）、美瑞醫療系統（Merit Medical Systems）、樂邁特（LeMaitre）、雅培（Abbott）、Endologix、血管移植物解決方案Solutions）、微創醫療器材（MicroPort）、Artivion、BD（貝克頓·迪金森公司）、Getinge 和 Cordis。血管移植物市場的各公司正採取多種策略來鞏固其市場地位。他們大力投資研發，以開發具有更高通暢率、生物相容性和更低併發症風險的創新移植物。策略性併購和合作有助於拓展產品組合和區域覆蓋範圍。許多公司專注於技術進步，包括藥物洗脫移植物、生物工程移植物和混合移植物。行銷活動、外科醫生教育計畫以及與醫院的緊密合作有助於提升品牌知名度和信任度。

目錄

第1章：方法論與範圍

第2章：執行概要

第3章：行業洞察

• 產業生態系分析
• 產業影響因素
  • 成長促進因素
    • 全球慢性病數量不斷增加
    • 發展中經濟體末期腎病患者數量不斷增加
    • 已開發國家的技術進步
    • 器官移植數量上升
  • 產業陷阱與挑戰
    • 發展中國家缺乏熟練人員
    • 移植感染和血栓形成的風險
  • 市場機遇
    • 生物可吸收和混合移植物的研究進展
    • 3D列印技術在移植片開發的應用日益廣泛
• 成長潛力分析
• 報銷方案
• 監管環境
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
• 技術格局
  • 當前技術趨勢
  • 新興技術
• 消費者分析
• 價值鏈分析
• 未來市場趨勢
• 關鍵投資和擴張趨勢
• 移植類型概述
• 接枝材料和塗層的創新
• 波特的分析
• PESTEL 分析
• 差距分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
  • 全球的
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
• 競爭定位矩陣
• 主要市場參與者的競爭分析
• 關鍵進展
  • 併購
  • 合作夥伴關係與合作
  • 新原料上市
  • 擴張計劃

第5章：市場估算與預測：依原料分類，2021-2034年

• 主要趨勢
• 聚酯接枝
• ePTFE移植物
• 生物合成接枝
• 聚氨酯接枝

第6章：市場估算與預測：依應用領域分類，2021-2034年

• 主要趨勢
• 血管內動脈瘤修復術
  • 腹主動脈瘤修復
  • 胸主動脈瘤修復術
• 血液透析通路
• 周邊血管修復

第7章：市場估算與預測：依最終用途分類，2021-2034年

• 主要趨勢
• 醫院
• 門診手術中心
• 其他最終用途

第8章：市場估算與預測：依地區分類，2021-2034年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Abbott
• Artivion
• B. Braun
• BD (Becton, Dickinson & Company)
• Cook Medical
• Cordis
• Endologix
• Getinge
• Gore
• LeMaitre
• Medtronic
• Merit Medical Systems
• MicroPort
• Terumo
• Vascular Graft Solutions

The Global Vascular Graft Market was valued at USD 3.6 billion in 2024 and is estimated to grow at a CAGR of 6.9% to reach USD 7.3 billion by 2034.

The market expansion is driven by the rising prevalence of cardiovascular disorders, technological innovations, and the growing incidence of end-stage renal disease (ESRD), along with an increase in surgical interventions worldwide. Vascular grafts are medical devices designed to replace, repair, or bypass damaged or diseased blood vessels, restoring normal blood flow. These grafts are manufactured from synthetic materials, biological tissues, or a hybrid of both. They are widely used in treatments for cardiovascular conditions, aneurysms, and hemodialysis access. Recent advancements, such as bioengineered grafts, heparin-coated ePTFE grafts, and hybrid materials, enhance compatibility, reduce thrombosis risk, and improve long-term patency. The market is also benefiting from the growing preference for minimally invasive and endovascular procedures, increasing use of tissue-engineered and biodegradable grafts, adoption of drug-eluting and coated grafts, and expansion in emerging markets, collectively propelling industry growth.

The polyester grafts segment held a 62.3% share in 2024. Polyester grafts are preferred for their durability, excellent biocompatibility, and proven long-term patency in vascular repair and bypass procedures. Their extensive clinical history and consistent performance in aortic and peripheral bypass surgeries have earned them high trust among surgeons, making them a staple in vascular procedures.

The hemodialysis access segment is expected to grow at a CAGR of 6.3% through 2034. Rising cases of ESRD and an increasing number of patients requiring long-term hemodialysis are driving demand for vascular grafts. Innovations in graft design that improve patency and minimize infection risks further support growth in this segment.

North America Vascular Graft Market held a 32.2% share in 2024. High rates of coronary artery disease, peripheral artery disease, and aortic aneurysms contribute to the region's strong demand. Well-established hospitals with specialized vascular surgery centers and access to advanced surgical technologies support the adoption of both open and endovascular graft procedures.

Key players in the Global Vascular Graft Market include Cook Medical, Gore, Terumo, Medtronic, B. Braun, Merit Medical Systems, LeMaitre, Abbott, Endologix, Vascular Graft Solutions, MicroPort, Artivion, BD (Becton, Dickinson & Company), Getinge, and Cordis. Companies in the Vascular Graft Market are adopting multiple strategies to strengthen their market position. They are heavily investing in research and development to create innovative grafts with improved patency, biocompatibility, and reduced complication risks. Strategic mergers, acquisitions, and partnerships help expand product portfolios and regional reach. Many firms focus on technological advancements, including drug-eluting, bioengineered, and hybrid grafts. Marketing campaigns, surgeon education programs, and strong hospital collaborations improve brand recognition and trust.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Raw Material trends
  • 2.2.3 Application trends
  • 2.2.4 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing number chronic diseases worldwide
    • 3.2.1.2 Growing number of end-stage renal disorders in developing economies
    • 3.2.1.3 Technological advancements in developed countries
    • 3.2.1.4 Rise in organ transplantation
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of skilled personnel in developing countries
    • 3.2.2.2 Risk of graft infection and thrombosis
  • 3.2.3 Market opportunities
    • 3.2.3.1 Development of bioresorbable and hybrid grafts
    • 3.2.3.2 Rising adoption of 3D printing in graft development
• 3.3 Growth potential analysis
• 3.4 Reimbursement scenario
• 3.5 Regulatory landscape
  • 3.5.1 North America
  • 3.5.2 Europe
  • 3.5.3 Asia Pacific
  • 3.5.4 LAMEA
• 3.6 Technology landscape
  • 3.6.1 Current technological trends
  • 3.6.2 Emerging technologies
• 3.7 Consumer analysis
• 3.8 Value chain analysis
• 3.9 Future market trends
• 3.10 Key investment and expansion trends
• 3.11 Overview of graft types
• 3.12 Innovations in graft materials and coatings
• 3.13 Porter's analysis
• 3.14 PESTEL analysis
• 3.15 Gap analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
  • 4.3.5 LAMEA
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New raw material launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Raw Material, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Polyester grafts
• 5.3 ePTFE grafts
• 5.4 Biosynthetic grafts
• 5.5 Polyurethane grafts

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Endovascular aneurysm repair
  • 6.2.1 Abdominal aortic aneurysm repair
  • 6.2.2 Thoracic aortic aneurysm repair
• 6.3 Hemodialysis access
• 6.4 Peripheral vascular repair

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Abbott
• 9.2 Artivion
• 9.3 B. Braun
• 9.4 BD (Becton, Dickinson & Company)
• 9.5 Cook Medical
• 9.6 Cordis
• 9.7 Endologix
• 9.8 Getinge
• 9.9 Gore
• 9.10 LeMaitre
• 9.11 Medtronic
• 9.12 Merit Medical Systems
• 9.13 MicroPort
• 9.14 Terumo
• 9.15 Vascular Graft Solutions